0001359824-17-000005.txt : 20170103 0001359824-17-000005.hdr.sgml : 20170103 20170103162704 ACCESSION NUMBER: 0001359824-17-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161230 FILED AS OF DATE: 20170103 DATE AS OF CHANGE: 20170103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arno Therapeutics, Inc CENTRAL INDEX KEY: 0001195116 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522286452 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ROUTE 31 NORTH STREET 2: SUITE 104 CITY: FLEMINGTON STATE: NJ ZIP: 08822 BUSINESS PHONE: (862) 703-7175 MAIL ADDRESS: STREET 1: 200 ROUTE 31 NORTH STREET 2: SUITE 104 CITY: FLEMINGTON STATE: NJ ZIP: 08822 FORMER COMPANY: FORMER CONFORMED NAME: LAURIER INTERNATIONAL INC DATE OF NAME CHANGE: 20021001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SUSSMAN S DONALD CENTRAL INDEX KEY: 0001044734 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52153 FILM NUMBER: 17502118 MAIL ADDRESS: STREET 1: 217 COMMECIAL STREET STREET 2: 5TH FLOOR CITY: PORTLAND STATE: ME ZIP: 04101 4 1 form4.xml X0306 4 2016-12-30 0001195116 Arno Therapeutics, Inc ARNI 0001044734 SUSSMAN S DONALD 888 E. LAS OLAS BLVD. SUITE 210 FT LAUDERDALE FL 33301 true See Footnote 1 Common Stock 2016-12-30 4 S 0 4285111 D 714285 D 2016 Series F Warrants (right to buy) 0.4375 2016-08-15 2021-08-15 Common Stock 357142 357142 D 2012 Series A Warrants 1.14 2016-12-30 4 S 0 1605809 D 2013-10-29 2017-11-26 Common Stock 1605809 0 D 2013 Series D Warrants 1.75 2016-12-30 4 S 0 1383702 D 2013-10-29 2018-10-29 Common Stock 1383702 0 D Commercial Street Capital LLC ("CSC") has a contractual right to designate one member of the Issuer's board of directors and has designated Steven B. Ruchefsky, a director of the Issuer, pursuant to such right. Accordingly, the Reporting Person, as a co-managing director of CSC, may be deemed to be a director by deputization for purposes of Section 16 of the Exchange Act. These shares of common stock or warrants exercisable for shares of common stock, as applicable, represent a pro rata distribution from CSC, and not a purchase or sale, of such shares or warrants by CSC to its members without consideration. These reported securities are included within a sale by the Reporting Person of all such securities for an aggregate price of $1,000. As a result of the Issuer's 8/15/16 private placement of common stock and Series F Warrants, the exercise prices and shares underlying the 2012 Series A Warrants and 2013 Series D Warrants were automatically adjusted to the exercise price and shares reflected pursuant to anti-dilution adjustment provisions in such warrants. /s/S. Donald Sussman 2016-12-30